Clinical trial
Sequential EHR Based Interventions to Increase Genetic Testing for Breast and Ovarian Cancer Predisposition
NCT05721326
Study timeline
Study start (actual)2023-05-01Date precision: day
Registry last updated2026-06-17
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Genetic Predisposition to Diseaseunresolved
Breast Cancer Femaleunresolved
Ovarian Cancerunresolved
Hereditary Breast and Ovarian Cancerunresolved
Hereditary Cancer Syndromeunresolved
Hereditary Diseasesunresolved
Gene Mutation-Related Cancerunresolved
Interventions
Sponsors & collaborators
Abramson Cancer Center at Penn Medicinelead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT05721326 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.